"Designing Growth Strategies is in our DNA"

Drug Eluting Stent (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI102612

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Cardiovascular Diseases, By Key Regions/ Key Countries, 2018
    2. New Product Launches, By Key Market Players
    3. Key Industry Developments, Such as Mergers & Acquisitions
    4. Pricing Analysis, By Key Brands, Key Players/ Key Regions
  5. Global Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Coronary Stenting
      2. Peripheral Stenting
    3. Market Analysis, Insights and Forecast – By Scaffold
      1. Cobalt-Chromium
      2. Platinum-Chromium
      3. Nitinol
      4. Others
    4. Market Analysis, Insights and Forecast – By Drug
      1. Sirolimus
      2. Paclitaxel
      3. Zotarolimus
      4. Everolimus
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Specialty Clinics
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Coronary Stenting
      2. Peripheral Stenting
    3. Market Analysis, Insights and Forecast – By Scaffold
      1. Cobalt-Chromium
      2. Platinum-Chromium
      3. Nitinol
      4. Others
    4. Market Analysis, Insights and Forecast – By Drug
      1. Sirolimus
      2. Paclitaxel
      3. Zotarolimus
      4. Everolimus
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Specialty Clinics
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Coronary Stenting
      2. Peripheral Stenting
    3. Market Analysis, Insights and Forecast – By Scaffold
      1. Cobalt-Chromium
      2. Platinum-Chromium
      3. Nitinol
      4. Others
    4. Market Analysis, Insights and Forecast – By Drug
      1. Sirolimus
      2. Paclitaxel
      3. Zotarolimus
      4. Everolimus
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Specialty Clinics
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Coronary Stenting
      2. Peripheral Stenting
    3. Market Analysis, Insights and Forecast – By Scaffold
      1. Cobalt-Chromium
      2. Platinum-Chromium
      3. Nitinol
      4. Others
    4. Market Analysis, Insights and Forecast – By Drug
      1. Sirolimus
      2. Paclitaxel
      3. Zotarolimus
      4. Everolimus
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Specialty Clinics
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Coronary Stenting
      2. Peripheral Stenting
    3. Market Analysis, Insights and Forecast – By Scaffold
      1. Cobalt-Chromium
      2. Platinum-Chromium
      3. Nitinol
      4. Others
    4. Market Analysis, Insights and Forecast – By Drug
      1. Sirolimus
      2. Paclitaxel
      3. Zotarolimus
      4. Everolimus
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Specialty Clinics
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Coronary Stenting
      2. Peripheral Stenting
    3. Market Analysis, Insights and Forecast – By Scaffold
      1. Cobalt-Chromium
      2. Platinum-Chromium
      3. Nitinol
      4. Others
    4. Market Analysis, Insights and Forecast – By Drug
      1. Sirolimus
      2. Paclitaxel
      3. Zotarolimus
      4. Everolimus
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Specialty Clinics
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
      1. Boston Scientific Corporation
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      2. Abbott
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Medtronic
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      4. Biotronik
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Terumo Corporation
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      6. MicroPort Scientific Corporation
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      7. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Drug Eluting Stents (DES) Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Drug Eluting Stents (DES) Market Value Share (%), by Type, 2018 & 2026

Figure 3:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Coronary Stenting, 2015-2026

Figure 4:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Peripheral Stenting, 2015-2026

Figure 5:  Global Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2018 & 2026

Figure 6:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Cobalt-Chromium, 2015-2026

Figure 7:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Platinum-Chromium, 2015-2026

Figure 8:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Nitinol, 2015-2026

Figure 9:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Others, 2015-2026

Figure 10:  Global Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2018 & 2026

Figure 11:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Sirolimus, 2015-2026

Figure 12:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Paclitaxel, 2015-2026

Figure 13:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Zotarolimus, 2015-2026

Figure 14:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Everolimus, 2015-2026

Figure 15:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Mod5, 2015-2026

Figure 16:  Global Drug Eluting Stents (DES) Market Value Share (%), by End User, 2018 & 2026

Figure 17:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Hospitals, 2015-2026

Figure 18:  Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Specialty Clinics, 2015-2026

Figure 19:  Global Drug Eluting Stents (DES) Market Value (US$ Mn), by Region, 2018 & 2026

Figure 20:  North America Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2018 & 2026

Figure 21:  North America Drug Eluting Stents (DES) Market Value Share (%), by Type, 2018

Figure 22:  North America Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2018 & 2026

Figure 23:  North America Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2018

Figure 24:  North America Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2018 & 2026

Figure 25:  North America Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2018

Figure 26:  North America Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2018 & 2026

Figure 27:  North America Drug Eluting Stents (DES) Market Value Share (%), by End User, 2018

Figure 28:  North America Drug Eluting Stents (DES) Market Value (US$ Mn), By Country, 2018 & 2026

Figure 29:  North America Drug Eluting Stents (DES) Market Value Share (%), By Country, 2018

Figure 30:  Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2018 & 2026

Figure 31:  Europe Drug Eluting Stents (DES) Market Value Share (%), by Type, 2018

Figure 32:  Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2018 & 2026

Figure 33:  Europe Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2018

Figure 34:  Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2018 & 2026

Figure 35:  Europe Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2018

Figure 36:  Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2018 & 2026

Figure 37:  Europe Drug Eluting Stents (DES) Market Value Share (%), by End User, 2018

Figure 38:  Europe Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 39:  Europe Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2018

Figure 40:  Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2018 & 2026

Figure 41:  Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by Type, 2018

Figure 42:  Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2018 & 2026

Figure 43:  Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2018

Figure 44:  Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2018 & 2026

Figure 45:  Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2018

Figure 46:  Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2018 & 2026

Figure 47:  Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by End User, 2018

Figure 48:  Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 49:  Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2018

Figure 50:  Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2018 & 2026

Figure 51:  Latin America Drug Eluting Stents (DES) Market Value Share (%), by Type, 2018

Figure 52:  Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2018 & 2026

Figure 53:  Latin America Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2018

Figure 54:  Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2018 & 2026

Figure 55:  Latin America Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2018

Figure 56:  Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2018 & 2026

Figure 57:  Latin America Drug Eluting Stents (DES) Market Value Share (%), by End User, 2018

Figure 58:  Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 59:  Latin America Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2018

Figure 60:  Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2018 & 2026

Figure 61:  Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by Type, 2018

Figure 62:  Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2018 & 2026

Figure 63:  Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2018

Figure 64:  Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2018 & 2026

Figure 65:  Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2018

Figure 66:  Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2018 & 2026

Figure 67:  Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by End User, 2018

Figure 68:  Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 69:  Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2018

Figure 70:  Global Drug Eluting Stents (DES) Market Share (%), By Company, 2018

Table 1:  Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 2:  Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2015–2026

Table 3:  Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2015–2026

Table 4:  Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2015–2026

Table 5:  Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 6:  North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 7:  North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2015-2026

Table 8:  North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2015-2026

Table 9:  North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 10:  North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 11:  Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 12:  Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2015-2026

Table 13:  Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2015-2026

Table 14:  Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 15:  Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 16:  Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 17:  Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2015-2026

Table 18:  Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2015-2026

Table 19:  Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 20:  Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 22:  Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2015-2026

Table 23:  Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2015-2026

Table 24:  Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 25:  Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 26:  Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 27:  Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2015-2026

Table 28:  Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2015-2026

Table 29:  Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 30:  Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

  • Apr, 2020
  • 2018
  • 2015-2017
  • 145

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X